Folawemimo Eve Oluwaseun Onigbinde, is a
Physician Assistant based in Fresno, Texas. Folawemimo Eve Oluwaseun Onigbinde is licensed to practice in * (Not Available) (license number ) and her current practice location is
1131 Noble Glen Dr, Fresno, Texas. She can be reached at her office (for appointments etc.) via phone at
(713) 444-4054.
NPI number for Folawemimo Eve Oluwaseun Onigbinde is 1679124507 and her current mailing address is 1131 Noble Glen Dr, Fresno, Texas. She
does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1679124507.
Provider's Profile
Full Name | Folawemimo Eve Oluwaseun Onigbinde |
---|
Gender | Female |
---|
Speciality | Physician Assistant |
---|
Location | 1131 Noble Glen Dr, Fresno, Texas |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
NPI Data:
- NPI Number: 1679124507
- Provider Enumeration Date: 09/23/2019
- Last Update Date: 09/23/2019
Medical Identifiers
Medical identifiers for Folawemimo Eve Oluwaseun Onigbinde such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1679124507 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
363A00000X | Physician Assistant | (* (Not Available)) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Folawemimo Eve Oluwaseun Onigbinde is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Folawemimo Eve Oluwaseun Onigbinde, 1131 Noble Glen Dr, Fresno, TX 77545-9689 Ph: () - | Folawemimo Eve Oluwaseun Onigbinde, 1131 Noble Glen Dr, Fresno, TX 77545-9689 Ph: (713) 444-4054 |
Reviews and Comments